The forecast for bladder malignant neoplasms mortality in Germany shows a slight year-on-year decline from 2024 to 2028, with death counts decreasing from 5.71 thousand in 2024 to 5.65 thousand by 2028. This represents a continuous but gradual decrease in mortality rates. The average Compound Annual Growth Rate (CAGR) over this period is indicative of a minor downward trend, which was also slightly observed in the years leading up to 2024.

Future trends to watch for:

Advancements in early detection and treatment may further reduce mortality rates.
Demographic shifts and public health policies could influence mortality trends.
Monitoring regional disparities within Germany will be crucial as healthcare access and outcomes may vary.